Patient-reported continuous clinical response to golimumab in adults with moderately to severely active ulcerative colitis: results from GO OBSERVE, a real-world European observational study

Marc Ferrante; Anja Schirbel; Marieke J Pierik; Thomas Haas; Mathurin Flamant; Ahmed Khalifa; George Philip; Freddy Cornillie; Alan G Meehan; Marinella Govoni

doi:10.1097/MEG.0000000000002374

Patient-reported continuous clinical response to golimumab in adults with moderately to severely active ulcerative colitis: results from GO OBSERVE, a real-world European observational study

Marc Ferrante, Anja Schirbel, Marieke J Pierik, Thomas Haas, Mathurin Flamant, Ahmed Khalifa, George Philip, Freddy Cornillie, Alan G Meehan, Marinella Govoni

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	646-654
Number of pages	9
Journal	European Journal of Gastroenterology & Hepatology
Volume	34
Issue number	6
Early online date	8 Apr 2022
DOIs	https://doi.org/10.1097/MEG.0000000000002374
Publication status	Published - Jun 2022

Keywords

Mayo score
REMISSION
golimumab
moderate-to
severe ulcerative colitis

Access to Document

10.1097/MEG.0000000000002374

Cite this

Ferrante, M., Schirbel, A., Pierik, M. J., Haas, T., Flamant, M., Khalifa, A., Philip, G., Cornillie, F., Meehan, A. G., & Govoni, M. (2022). Patient-reported continuous clinical response to golimumab in adults with moderately to severely active ulcerative colitis: results from GO OBSERVE, a real-world European observational study. European Journal of Gastroenterology & Hepatology, 34(6), 646-654. https://doi.org/10.1097/MEG.0000000000002374

Ferrante, Marc ; Schirbel, Anja ; Pierik, Marieke J ; Haas, Thomas ; Flamant, Mathurin ; Khalifa, Ahmed ; Philip, George ; Cornillie, Freddy ; Meehan, Alan G ; Govoni, Marinella. / Patient-reported continuous clinical response to golimumab in adults with moderately to severely active ulcerative colitis : results from GO OBSERVE, a real-world European observational study. In: European Journal of Gastroenterology & Hepatology. 2022 ; Vol. 34, No. 6. pp. 646-654.

@article{782c09b80e9c4fc3b2aee972b02fc192,

title = "Patient-reported continuous clinical response to golimumab in adults with moderately to severely active ulcerative colitis: results from GO OBSERVE, a real-world European observational study",

keywords = "Mayo score, REMISSION, golimumab, moderate-to, severe ulcerative colitis",

author = "Marc Ferrante and Anja Schirbel and Pierik, {Marieke J} and Thomas Haas and Mathurin Flamant and Ahmed Khalifa and George Philip and Freddy Cornillie and Meehan, {Alan G} and Marinella Govoni",

year = "2022",

month = jun,

doi = "10.1097/MEG.0000000000002374",

language = "English",

volume = "34",

pages = "646--654",

journal = "European Journal of Gastroenterology & Hepatology",

issn = "0954-691X",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

number = "6",

}

Ferrante, M, Schirbel, A, Pierik, MJ, Haas, T, Flamant, M, Khalifa, A, Philip, G, Cornillie, F, Meehan, AG & Govoni, M 2022, 'Patient-reported continuous clinical response to golimumab in adults with moderately to severely active ulcerative colitis: results from GO OBSERVE, a real-world European observational study', European Journal of Gastroenterology & Hepatology, vol. 34, no. 6, pp. 646-654. https://doi.org/10.1097/MEG.0000000000002374

Patient-reported continuous clinical response to golimumab in adults with moderately to severely active ulcerative colitis : results from GO OBSERVE, a real-world European observational study. / Ferrante, Marc; Schirbel, Anja; Pierik, Marieke J; Haas, Thomas; Flamant, Mathurin; Khalifa, Ahmed; Philip, George; Cornillie, Freddy; Meehan, Alan G; Govoni, Marinella.

In: European Journal of Gastroenterology & Hepatology, Vol. 34, No. 6, 06.2022, p. 646-654.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Patient-reported continuous clinical response to golimumab in adults with moderately to severely active ulcerative colitis

T2 - results from GO OBSERVE, a real-world European observational study

AU - Ferrante, Marc

AU - Schirbel, Anja

AU - Pierik, Marieke J

AU - Haas, Thomas

AU - Flamant, Mathurin

AU - Khalifa, Ahmed

AU - Philip, George

AU - Cornillie, Freddy

AU - Meehan, Alan G

AU - Govoni, Marinella

PY - 2022/6

Y1 - 2022/6

KW - Mayo score

KW - REMISSION

KW - golimumab

KW - moderate-to

KW - severe ulcerative colitis

U2 - 10.1097/MEG.0000000000002374

DO - 10.1097/MEG.0000000000002374

M3 - Article

C2 - 35412484

VL - 34

SP - 646

EP - 654

JO - European Journal of Gastroenterology & Hepatology

JF - European Journal of Gastroenterology & Hepatology

SN - 0954-691X

IS - 6

ER -

Ferrante M, Schirbel A, Pierik MJ, Haas T, Flamant M, Khalifa A et al. Patient-reported continuous clinical response to golimumab in adults with moderately to severely active ulcerative colitis: results from GO OBSERVE, a real-world European observational study. European Journal of Gastroenterology & Hepatology. 2022 Jun;34(6):646-654. https://doi.org/10.1097/MEG.0000000000002374